Trial Profile
Pharmacokinetic profile of Myfortic (enteric coated mycophenolate sodium) in a rapid steroid withdrawal protocol in combination with tacrolimus in stable renal transplant recipients in the fed and fasting state
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Tacrolimus
- Indications Renal transplant rejection
- Focus Pharmacokinetics
- 11 Mar 2011 Planned end date changed from Dec 2008 to Jul 2011 as reported by ClinicalTrials.gov.
- 11 Mar 2011 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 24 Jan 2008 New trial record.